Sera Prognostics Inc banner

Intrinsic Value

The intrinsic value of Sera Prognostics Inc (SERA) under the Base Case is 1.57 USD per share. Compared with the current market price of 2.04 USD, the stock appears Overvalued by 23% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

SERA Intrinsic Value
$1.57
Overvaluation 23%
Intrinsic Value
Price $2.04

SERA is cheaper than usual. Still overvalued, but less so than on 97% of days in the past 5 years.

Monitor SERA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $1.25
Get notified when the price drops into your buy zone
Current Price $2.04
Intrinsic Value $1.57
Margin of Safety 20% $1.25
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to SERA

Fundamental Analysis

What Sera Prognostics Does

Biotechnology Health Care

Sera Prognostics is a women’s health diagnostics company focused on predicting the risk of preterm birth. Its main product is a blood test sold to obstetric providers and health systems that helps identify pregnant patients who may need closer monitoring and earlier care planning. The company’s goal is to give doctors a clearer picture of pregnancy risk before labor starts.

Headquarters
United States of America US
Employees
71
IPO date
Jul 15, 2021
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Sera Prognostics Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

SERA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SERA stock?

The intrinsic value for Sera Prognostics Inc (SERA) under the Base Case is 1.57 USD.

Is SERA stock undervalued or overvalued?

Compared with the current market price of 2.04 USD, the stock appears Overvalued by 23% .

Back to Top